E-LIB Suche - Ergebnisse für: Levitan, Bennett

1

Benefit-risk assessment of vaccines:

Kochhar, Sonali ; Izurieta, Hector S. ; Chandler, Rebecca E....
Vaccine. 42 (2024) 4 - p. 969-971 , 2024

2

How to Present a Decision Object in Health Preference Resea..:

Mühlbacher, Axel C. ; de Bekker-Grob, Esther W. ; Rivero-Arias, Oliver..
The Patient - Patient-Centered Outcomes Research. , 2024

Link: https://doi.org/10.1007/..

3

The Brighton collaboration standardized module for vaccine ..:

Levitan, Bennett ; Hadler, Stephen C. ; Hurst, William...
Vaccine. 42 (2024) 4 - p. 972-986 , 2024

Link: https://doi.org/10.1016/..

4

Quantitative Benefit–Risk Evaluation of Rivaroxaban in Pati..:

Yuan, Zhong ; Levitan, Bennett ; Deng, Hsiaowei...
Journal of the American Heart Association. 13 (2024) 8 - p. , 2024

Link: https://doi.org/10.1161/..

5

A Benefit–Risk Conceptual Framework for Biologic Use During..:

Bozzi, Laura M. ; Jacobson, Melanie H. ; Yost, Emily...
Clinical Pharmacology & Therapeutics. 115 (2024) 6 - p. 1251-1257 , 2024

Link: https://doi.org/10.1002/..

6

Current Practices and Challenges When Submitting Patient Ex..:

Pinto, Cathy Anne ; Tervonen, Tommi ; Jimenez-Moreno, Cecilia...
The Patient - Patient-Centered Outcomes Research. 17 (2023) 2 - p. 147-159 , 2023

Link: https://doi.org/10.1007/..

7

How can patient preferences be used and communicated in the..:

Janssens, Rosanne ; Barbier, Liese ; Muller, Mireille...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Use of Patient Preferences Data Regarding Multiple Risks to..:

Montano-Campos, J. Felipe ; Gonzalez, Juan Marcos ; Rickert, Timothy...
MDM Policy & Practice. 8 (2023) 1 - p. 238146832211487 , 2023

Link: https://doi.org/10.1177/..

9

Illustrating Emerging Good Practices for Quantitative Benef..:

Lackey, Leila G. ; Ng, Xinyi ; Veldwijk, Jorien...
Value in Health. 26 (2023) 4 - p. 519-527 , 2023

Link: https://doi.org/10.1016/..

10

Quantitative Benefit-Risk Assessment in Medical Product Dec..:

Tervonen, Tommi ; Veldwijk, Jorien ; Payne, Katherine...
Value in Health. 26 (2023) 4 - p. 449-460 , 2023

Link: https://doi.org/10.1016/..

11

Treatment preferences in relation to fatigue of patients wi..:

Tervonen, Tommi ; Fox, Robert J ; Brooks, Anne...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9 (2023) 1 - p. 205521732211503 , 2023

Link: https://doi.org/10.1177/..

12

Benefit–Risk Assessment of Rivaroxaban for Extended Thrombo..:

Raskob, Gary E. ; Ageno, Walter ; Albers, Gregory...
Journal of the American Heart Association. 11 (2022) 20 - p. , 2022

Link: https://doi.org/10.1161/..

13

The relevance of fatigue to relapse rate in multiple sclero..:

Fox, Robert J ; Tervonen, Tommi ; Phillips-Beyer, Andrea...
Multiple Sclerosis Journal. 29 (2022) 3 - p. 427-435 , 2022

Link: https://doi.org/10.1177/..

14

U.S. Food and Drug Administration's Patient-Focused Drug De..:

Katz, Eva G. ; McNulty, Pauline ; Levitan, Bennett...
Therapeutic Innovation & Regulatory Science. 56 (2021) 1 - p. 38-46 , 2021

Link: https://doi.org/10.1007/..

15

Correction to: Patient Preferences in Rare Diseases: A Qual..:

Jimenez-Moreno, A. Cecilia ; van Overbeeke, Eline ; Pinto, Cathy Anne...
The Patient - Patient-Centered Outcomes Research. 14 (2021) 5 - p. 693-693 , 2021

Link: https://doi.org/10.1007/..